Atlas Trials

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Clinical trial NCT02402530 · COMPLETED

Trial details

NCT number
NCT02402530
Sponsor
Grünenthal GmbH
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Complex Regional Pain Syndrome, Type I
Start date
2015-04-01
Primary completion
2016-08-01
Enrollment
459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.